Acorah Software Products - Accounts Production 19.3.600 false true 31 March 2025 1 April 2024 false 1 April 2025 31 March 2026 31 March 2026 05262428 G S Wickham C L Wickham iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 05262428 2025-03-31 05262428 2026-03-31 05262428 2025-04-01 2026-03-31 05262428 frs-core:CurrentFinancialInstruments 2026-03-31 05262428 frs-core:BetweenOneFiveYears 2026-03-31 05262428 frs-core:ComputerEquipment 2025-04-01 2026-03-31 05262428 frs-core:FurnitureFittings 2025-04-01 2026-03-31 05262428 frs-core:NetGoodwill 2026-03-31 05262428 frs-core:NetGoodwill 2025-04-01 2026-03-31 05262428 frs-core:NetGoodwill 2025-03-31 05262428 frs-core:LandBuildings 2026-03-31 05262428 frs-core:LandBuildings 2025-04-01 2026-03-31 05262428 frs-core:LandBuildings 2025-03-31 05262428 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2025-04-01 2026-03-31 05262428 frs-core:PlantMachinery 2026-03-31 05262428 frs-core:PlantMachinery 2025-04-01 2026-03-31 05262428 frs-core:PlantMachinery 2025-03-31 05262428 frs-core:WithinOneYear 2026-03-31 05262428 frs-core:ShareCapital 2026-03-31 05262428 frs-core:RetainedEarningsAccumulatedLosses 2026-03-31 05262428 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 05262428 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 05262428 frs-bus:SmallEntities 2025-04-01 2026-03-31 05262428 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 05262428 frs-bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 05262428 frs-bus:Director1 2025-04-01 2026-03-31 05262428 frs-bus:CompanySecretary1 2025-04-01 2026-03-31 05262428 frs-countries:EnglandWales 2025-04-01 2026-03-31 05262428 2024-03-31 05262428 2025-03-31 05262428 2024-04-01 2025-03-31 05262428 frs-core:CurrentFinancialInstruments 2025-03-31 05262428 frs-core:BetweenOneFiveYears 2025-03-31 05262428 frs-core:WithinOneYear 2025-03-31 05262428 frs-core:ShareCapital 2025-03-31 05262428 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31
Registered number: 05262428
Exminster Pharmacy Limited
Unaudited Financial Statements
For The Year Ended 31 March 2026
Exminster Pharmacy Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—6

Page 1
Exminster Pharmacy Limited
Balance Sheet
As At 31 March 2026
Balance Sheet
Registered number: 05262428

| 2026 | 2025
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Intangible Assets | 4 |  | 15,750 |  | 47,250
Tangible Assets | 5 |  | 3,324 |  | 4,015
|  |  | 19,074 |  | 51,265
CURRENT ASSETS
Stocks |  | 33,844 |  | 34,283 |
Debtors | 6 | 220,072 |  | 216,135 |
Cash at bank and in hand |  | 416,401 |  | 424,206 |
|  | 670,317 |  | 674,624 |
Creditors: Amounts Falling Due Within One Year | 7 | (106,978 ) |  | (146,668 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 563,339 |  | 527,956
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 582,413 |  | 579,221
PROVISIONS FOR LIABILITIES
Deferred Taxation |  |  | (372 ) |  | (469 )
NET ASSETS |  |  | 582,041 |  | 578,752
CAPITAL AND RESERVES
Called up share capital | 8 |  | 100 |  | 100
Profit and Loss Account |  |  | 581,941 |  | 578,652
SHAREHOLDERS' FUNDS |  |  | 582,041 |  | 578,752

Page 1
Page 2
Exminster Pharmacy Limited
Balance Sheet (continued)
As At 31 March 2026
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

G S Wickham Director
18 August 2026

The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Exminster Pharmacy Limited
Notes to the Financial Statements
For The Year Ended 31 March 2026
Notes to the Financial Statements
1. General Information
Exminster Pharmacy Limited is a private company, limited by shares, incorporated in England & Wales, registered number 05262428 . The registered office is 67 Cowick Street , Exeter, Devon, EX4 1HW.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts and value added taxes. Turnover includes revenue earned from the sale of goods and services.
2.3. Intangible Fixed Assets and Amortisation - Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the separable net assets. It is amortised to profit and loss account over its estimated economic life of 10 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Leasehold | in accordance with the property
Plant & Machinery | 20% reducing balance
Fixtures & Fittings | 20% reducing balance
Computer Equipment | 33% reducing balance

2.5. Leasing and Hire Purchase Contracts
Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account as incurred.
2.6. Stocks and Work in Progress
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks.
Page 3
Page 4
Exminster Pharmacy Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 March 2026
2.7. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
2.8. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 6 (2025: 6)
6 6
4. Intangible Assets

| Goodwill
--- | ---
| £
Cost
As at 1 April 2025 | 450,000
As at 31 March 2026 | 450,000
Amortisation
As at 1 April 2025 | 402,750
Provided during the period | 31,500
As at 31 March 2026 | 434,250

...CONTINUED
Page 4
Page 5
Exminster Pharmacy Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 March 2026

Net Book Value
As at 31 March 2026 | 15,750
As at 1 April 2025 | 47,250

5. Tangible Assets

| Land & Buildings | Plant & Machinery etc. | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 April 2025 | 10,710 | 32,497 | 43,207
As at 31 March 2026 | 10,710 | 32,497 | 43,207
Depreciation
As at 1 April 2025 | 8,570 | 30,622 | 39,192
Provided during the period | 302 | 389 | 691
As at 31 March 2026 | 8,872 | 31,011 | 39,883
Net Book Value
As at 31 March 2026 | 1,838 | 1,486 | 3,324
As at 1 April 2025 | 2,140 | 1,875 | 4,015

6. Debtors

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 79,000 |  | 75,380
Amounts owed by group undertakings | 110,657 |  | 112,167
Other debtors | 30,415 |  | 28,588
| 220,072 |  | 216,135

7. Creditors: Amounts Falling Due Within One Year

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Trade creditors | 95,382 |  | 128,035
Other creditors | 1,265 |  | 2,742
Taxation and social security | 10,331 |  | 15,891
| 106,978 |  | 146,668

Page 5
Page 6
Exminster Pharmacy Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 March 2026
8. Share Capital

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

9. Other Commitments
The total of future minimum lease payments under non-cancellable operating leases are as following:

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Not later than one year | 17,750 |  | 15,000
Later than one year and not later than five years | 22,188 |  | -
| 39,938 |  | 15,000

10. Related Party Transactions
The company is a subsidiary in a small group. The parent company of that group is George Wickham Limited whose registered office is Luxtons The Pharmacy, 67 Cowick Street, Exeter EX4 1HW.
A loan subsisted between the company and the parent company as follows:
Amounts loaned by the parent company £4,640 (2025 - £6,389)
Amounts repaid to the parent company £3,130 (2025 - £689)
Balance owing by the parent company at the balance sheet date £110,657 (2025 - owing by the parent company £112,167)
The loan is unsecured, interest free and repayable on demand.
Page 6